Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: Reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine-Reference-Cited by-同舟云学术

Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: Reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine

Published:2007-09 Issue:9 Volume:82 Page:792-797
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Richardson Stephen K.,Newton Sarah B.,Bach Tami L.,Budgin Jeanne B.,Benoit Bernice M.,Lin Julie H.,Yoon Jessica S.,Wysocka Maria,Abrams Charles S.,Rook Alain H.

Publisher

Wiley

Subject

Hematology

Reference21 articles.

1. Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas

2. Increased CCR4 Expression in Cutaneous T Cell Lymphoma

3. CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin

4. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides

5. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunobiology and treatment of cutaneous T-cell lymphoma;Expert Review of Clinical Immunology;2024-03-07

2. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer;Pharmacology & Therapeutics;2023-12

3. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas;Cells;2023-11-04

4. CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas;Skin Health and Disease;2023-02-12

5. Phototherapy combined with systemic agents for mycosis fungoides;Vestnik dermatologii i venerologii;2023-01-27